» Articles » PMID: 16651417

Collagen Type I Induces Disruption of E-cadherin-mediated Cell-cell Contacts and Promotes Proliferation of Pancreatic Carcinoma Cells

Overview
Journal Cancer Res
Specialty Oncology
Date 2006 May 3
PMID 16651417
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic cancer is characterized by its invasiveness, early metastasis, and the production of large amounts of extracellular matrix (ECM). We analyzed the influence of type I collagen and fibronectin on the regulation of cellular adhesion in pancreatic cancer cell lines to characterize the role of ECM proteins in the development of pancreatic cancer. We show that collagen type I is able to initiate a disruption of the E-cadherin adhesion complex in pancreatic carcinoma cells. This is due to the increased tyrosine phosphorylation of the complex protein beta-catenin, which correlates with collagen type I-dependent activation of the focal adhesion kinase and its association with the E-cadherin complex. The activation and recruitment of focal adhesion kinase to the E-cadherin complex depends on the interaction of type I collagen with beta1-containing integrins and an integrin-mediated activation of the cellular kinase Src. The disassembly of the E-cadherin adhesion complex correlates with the nuclear translocation of beta-catenin, which leads to an increasing expression of the beta-catenin-Lef/Tcf target genes, cyclin D1 and c-myc. In addition to that, cells grown on collagen type I show enhanced cell proliferation. We show that components of the ECM, produced by the tumor, contribute to invasiveness and metastasis by reducing E-cadherin-mediated cell-cell adhesion and enhance proliferation in pancreatic tumor cells.

Citing Articles

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E J Hematol Oncol. 2025; 18(1):6.

PMID: 39806516 PMC: 11733683. DOI: 10.1186/s13045-024-01634-6.


High levels of fibrotic tumor components are associated with recurrence and intratumoral immune status in advanced colorectal cancer patients.

Dorjkhorloo G, Shiraishi T, Erkhem-Ochir B, Sohda M, Okami H, Yamaguchi A Sci Rep. 2024; 14(1):30735.

PMID: 39730445 PMC: 11680924. DOI: 10.1038/s41598-024-80489-w.


From ductal carcinoma in situ to invasive breast cancer: the prognostic value of the extracellular microenvironment.

Hulahan T, Angel P J Exp Clin Cancer Res. 2024; 43(1):329.

PMID: 39716322 PMC: 11664872. DOI: 10.1186/s13046-024-03236-z.


Integrin α2 in the microenvironment and the tumor compartment of digestive (gastrointestinal) cancers: emerging regulators and therapeutic opportunities.

Liu T, Gu Y, Zhang Y, Li Y Front Oncol. 2024; 14:1439709.

PMID: 39568561 PMC: 11576383. DOI: 10.3389/fonc.2024.1439709.


CTHRC1 fibroblasts and SPP1 macrophages synergistically contribute to pro-tumorigenic tumor microenvironment in pancreatic ductal adenocarcinoma.

Li E, Cheung H, Ma S Sci Rep. 2024; 14(1):17412.

PMID: 39075108 PMC: 11286765. DOI: 10.1038/s41598-024-68109-z.